Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study

AIM: The main objective of the current study was to explore the value of risk-adjustment when comparing (i.e. benchmarking) long-term overall survival (OS) in breast cancer (BC) between Swedish regions. We performed risk-adjusted benchmarking of 5- and 10-year OS after HER2-positive early BC diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Thurell, Jacob, Manouchehri, Narges, Fredriksson, Irma, Wilking, Ulla, Bergh, Jonas, Ryden, Lisa, Koppert, Linetta B., Karsten, Maria M., Kiani, Narsis A., Hedayati, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272493/
https://www.ncbi.nlm.nih.gov/pubmed/37295176
http://dx.doi.org/10.1016/j.breast.2023.05.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272493/
https://www.ncbi.nlm.nih.gov/pubmed/37295176
http://dx.doi.org/10.1016/j.breast.2023.05.008

Ejemplares similares